Published in Ann Neurol on April 01, 1980
Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry (1984) 2.14
Functional role of unmyelinated tactile afferents in human hairy skin: sympathetic response and perceptual localization. Exp Brain Res (2007) 1.17
Body sway and vibration perception thresholds in normal aging and in patients with polyneuropathy. J Neurol Neurosurg Psychiatry (1995) 1.06
Feeling good: on the role of C fiber mediated touch in interoception. Exp Brain Res (2010) 0.98
Sensory neuropathies including painful and toxic neuropathies. J Neurol (1997) 0.96
Subacute sensory neuropathy with remission: an association with lymphoma. J Neurol Neurosurg Psychiatry (1982) 0.91
The fusimotor and reafferent origin of the sense of force and weight. J Physiol (2011) 0.90
Structure and function of the somatosensory system: a neurotoxicological perspective. Environ Health Perspect (1982) 0.87
Ganglioradiculitis in the dog. A clinical, light- and electron-microscopic study. Acta Neuropathol (1983) 0.79
Rehabilitation after sensory neuronopathy syndrome. J R Soc Med (1998) 0.77
A case of Hodgkin's lymphoma associated with sensory neuropathy. J Korean Med Sci (2004) 0.76
Cortical responses to Aδ-fiber stimulation: magnetoencephalographic recordings in a subject lacking large myelinated afferents. Cereb Cortex (2009) 0.76
Tissue engineering the mechanosensory circuit of the stretch reflex arc with human stem cells: Sensory neuron innervation of intrafusal muscle fibers. Biomaterials (2017) 0.75
Encoding of Touch Intensity But Not Pleasantness in Human Primary Somatosensory Cortex. J Neurosci (2016) 0.75
Subacute neuronopathy in a young man: a possible association with tetracycline treatment. Neurol Int (2011) 0.75
Acute ataxic neuropathy with hyperreflexia. J Neurol (2012) 0.75
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science (1969) 2.32
Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol) Neurology (1993) 2.27
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Glue-sniffing neuropathy. Arch Neurol (1975) 1.99
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol (1974) 1.86
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain (1976) 1.84
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol (1977) 1.80
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74
Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73
Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J Neuropathol Exp Neurol (1977) 1.69
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol (1975) 1.66
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
Fatty acid abnormality in adrenoleukodystrophy. J Neurochem (1976) 1.58
Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain (1975) 1.56
Giant axonal neuropathy. Pediatrics (1972) 1.53
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51
Sensory perineuritis. Arch Neurol (1972) 1.51
Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50
Sin cib-syn: Accent on glutamate. N Engl J Med (1968) 1.45
Diabetic neuropathy. Ann Neurol (1984) 1.44
Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study. J Cell Biol (1967) 1.41
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
The role of the cranial CT scan in municipal hospitals. Am J Public Health (1980) 1.39
The enlarging view of hexacarbon neurotoxicity. Crit Rev Toxicol (1980) 1.36
The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain (1972) 1.36
Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol (1970) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol (1974) 1.31
Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30
Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann Neurol (1979) 1.29
A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can J Neurol Sci (1974) 1.29
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology (1993) 1.28
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25
Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science (1978) 1.24
Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity. J Neurol Sci (1972) 1.23
Toxic neuropathies. Neurology (1979) 1.22
Hereditary sensory neuropathy. A clinical and ultrastructural study. J Neurol Sci (1970) 1.22
Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry (1975) 1.21
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Neurotoxic fragrance produces ceroid and myelin disease. Science (1979) 1.17
Distal neuropathy in experimental diabetes mellitus. Ann Neurol (1980) 1.15
A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Can J Neurol Sci (1974) 1.15
Invited review: peripheral neuropathy in Sjogren's syndrome. Muscle Nerve (1990) 1.15
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Renaut bodies. A forgotten endoneurial structure. J Neuropathol Exp Neurol (1973) 1.14
Recognizing neurotoxic disease. Neurology (1987) 1.14
Pain due to peripheral nerve damage: an hypothesis. Neurology (1984) 1.14
Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet (1986) 1.14
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med (1993) 1.11
Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. J Neurol Neurosurg Psychiatry (1979) 1.11
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am J Pathol (1974) 1.10
Demyelinating neuropathy accompanying Lyme disease. Neurology (1982) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Acute stroke therapy trials: problems in patient accrual. Stroke (1988) 1.09
Organic solvent neurotoxicity. Facts and research needs. Scand J Work Environ Health (1985) 1.08
Adreno-leukodystrophy (sex-linked Schilder disease). Ultrastructural demonstration of specific cytoplasmic inclusions in the central nervous system. Arch Neurol (1974) 1.08
Thermal sensitivity tester. Device for quantitative assessment of thermal sense in diabetic neuropathy. Diabetes (1986) 1.07
An ultrastructural study of the inner core of the Pacinian corpuscle. J Neurocytol (1973) 1.06
The significance of giant vacuolation of endoneurial fibroblasts. Acta Neuropathol (1971) 1.05
Schilder's disease. Sex-linked recessive transmission with specific adrenal changes. Arch Neurol (1972) 1.05
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Intra-axonal bacilli in lepromatous leprosy. A light and electron microscopic study. Acta Neuropathol (1974) 1.04
Comparison of clinical couse and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes (1981) 1.04
Heart block in polymyositis. N Engl J Med (1971) 1.03
Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack. Brain (1970) 1.03
Pupil-involving third-nerve palsy and carotid stenosis: rapid recovery following endarterectomy. Ann Neurol (1997) 1.02
In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol (1982) 1.02
Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology (1993) 1.01
Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol (1982) 1.00
The testis in adreno-leukodystrophy. Am J Pathol (1981) 1.00
Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J Infect Dis (1999) 0.99
Patterns of recovery in the Guillain-Barre syndromes. Neurology (1997) 0.99
Proximal diabetic neuropathy. Ann Neurol (1977) 0.99
Clioquinol and 2,5-hexanedione induce different types of distal axonopathy in the dog. Acta Neuropathol (1979) 0.98
Lathyrism: a neurotoxic disease. Neurobehav Toxicol Teratol (1984) 0.97